Saturday, May 30, 2015

Pfizer’s Drug Delays Progression in Recurrent Breast Cancer

… again in women with advanced breast cancer who’d been previously treated … of the deadliest forms of breast cancer by U.S. regulators in … women with advanced ER-positive, HER2-negative breast cancer. In a study of 521 …

No comments:

Post a Comment